Clinical Trial Update: UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating indefinite lenalidomide maintenance versus observation in currently event-free patients with multiple myeloma. Results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-09-10